Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
Add more filters











Publication year range
1.
Biomed Pharmacother ; 168: 115842, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37925936

ABSTRACT

As a subclass of ionotropic glutamate receptors (iGluRs), α-amino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid (AMPA) receptors have been implicated in various neurological disorders and neurodegenerative diseases. To further our understanding of AMPA receptor-related disorders in the central nervous system (CNS), it is important to be able to image and quantify AMPA receptors in vivo. In this study, we identified a novel F-containing AMPA positive allosteric modulator (PAM) 6 as a potential lead compound. Molecular docking studies and CNS PET multi-parameter optimization (MPO) analysis were used to predict the absorption, distribution, metabolism, and excretion (ADME) characteristics of 6 as a PET probe. The resulting PET probe, [18F]6 (codename [18F]AMPA-2109), was successfully radiolabeled and demonstrated excellent blood-brain barrier (BBB) permeability and high brain uptake in rodents and non-human primates. However, [18F]6 did not show substantial specific binding in the rodent or non-human primate brain. Further medicinal chemistry efforts are necessary to improve specific binding, and our work may serve as a starting point for the design of novel 18F-labeled AMPA receptor-targeted PET radioligands aimed for clinical translation.


Subject(s)
Receptors, AMPA , Thiadiazines , Animals , Receptors, AMPA/metabolism , Thiadiazines/metabolism , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid , Molecular Docking Simulation , Brain/diagnostic imaging , Brain/metabolism , Positron-Emission Tomography/methods , Rodentia/metabolism
2.
Eur J Med Chem ; 219: 113441, 2021 Jul 05.
Article in English | MEDLINE | ID: mdl-33862517

ABSTRACT

Cumulative evidence suggests that ß-amyloid and oxidative stress are closely related with each other and play key roles in the process of Alzheimer's disease (AD). Multitarget regulation of both pathways might represent a promising therapeutic strategy. Here, a series of selenium-containing compounds based on ebselen and verubecestat were designed and synthesized. Biological evaluation showed that 13f exhibited good BACE-1 inhibitory activity (IC50 = 1.06 µΜ) and potent GPx-like activity (ν0 = 183.0 µM min-1). Aß production experiment indicated that 13f could reduce the secretion of Aß1-40 in HEK APPswe 293T cells. Moreover, 13f exerted a cytoprotective effect against the H2O2 or 6-OHDA caused cell damage via alleviation of intracellular ROS, mitochondrial dysfunction, Ca2+ overload and cell apoptosis. The mechanism studies indicated that 13f exhibited cytoprotective effect by activating the Keap1-Nrf2-ARE pathway and stimulating downstream anti-oxidant protein including HO-1, NQO1, TrxR1, GCLC, and GCLM. In addition, 13f significantly reduced the production of NO and IL-6 induced by LPS in BV2 cells, which confirmed its anti-inflammatory activity as a Nrf2 activator. The BBB permeation assay predicted that 13f was able to cross the BBB. In summary, 13f might be a promising multi-target-directed ligand for the treatment of AD.


Subject(s)
Amyloid Precursor Protein Secretases/antagonists & inhibitors , Aspartic Acid Endopeptidases/antagonists & inhibitors , Ligands , NF-E2-Related Factor 2/antagonists & inhibitors , Neuroprotective Agents/chemical synthesis , Alzheimer Disease/drug therapy , Amyloid Precursor Protein Secretases/metabolism , Amyloid beta-Peptides/metabolism , Antioxidants/metabolism , Aspartic Acid Endopeptidases/metabolism , Azoles/chemistry , Azoles/metabolism , Azoles/pharmacology , Azoles/therapeutic use , Binding Sites , Blood-Brain Barrier/drug effects , Blood-Brain Barrier/metabolism , Cyclic S-Oxides/chemistry , Cyclic S-Oxides/metabolism , Cyclic S-Oxides/pharmacology , Cyclic S-Oxides/therapeutic use , Drug Design , Humans , Interleukin-6/metabolism , Isoindoles , Mitochondria/drug effects , Mitochondria/metabolism , Molecular Docking Simulation , NF-E2-Related Factor 2/metabolism , Neuroprotective Agents/metabolism , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Organoselenium Compounds/chemistry , Organoselenium Compounds/metabolism , Organoselenium Compounds/pharmacology , Organoselenium Compounds/therapeutic use , Oxidative Stress/drug effects , Peptide Fragments/metabolism , Reactive Oxygen Species/metabolism , Selenium/chemistry , Signal Transduction/drug effects , Thiadiazines/chemistry , Thiadiazines/metabolism , Thiadiazines/pharmacology , Thiadiazines/therapeutic use
3.
Eur J Med Chem ; 208: 112847, 2020 Dec 15.
Article in English | MEDLINE | ID: mdl-33022479

ABSTRACT

Based on our prior work, we reported the design, synthesis, and biological evaluation of fifty-two new triazolothiadiazine-based analogues of CA-4 and their preliminary structure-activity relationship. Among synthesized compounds, Iab was found to be the most potent derivative possessing IC50 values ranging from single-to double-digit nanomolar in vitro, and also exhibited excellent selectivity over the normal human embryonic kidney HEK-293 cells (IC50 > 100 µM). Further mechanistic studies revealed that Iab significantly blocked tubulin polymerization and disrupted the intracellular microtubule network of A549 cells. Moreover, Iab induced G2/M cell cycle arrest by regulation of p-cdc2 and cyclin B1 expressions, and caused cell apoptosis through up-regulating cleaved PARP and cleaved caspase-3 expressions, and down-regulating of Bcl-2. Importantly, in vivo, Iab effectively suppressed tumor growth of A549 lung cancers in a xenograft mouse model without obvious signs of toxicity, confirming its potential as a promising candidate for cancer treatment.


Subject(s)
Antineoplastic Agents/therapeutic use , Neoplasms/drug therapy , Thiadiazines/therapeutic use , Triazoles/therapeutic use , Tubulin Modulators/therapeutic use , Tubulin/metabolism , A549 Cells , Animals , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/metabolism , Apoptosis/drug effects , Binding Sites , Cell Proliferation/drug effects , Female , G2 Phase Cell Cycle Checkpoints/drug effects , HEK293 Cells , Humans , Mice, Inbred BALB C , Molecular Structure , Protein Binding , Structure-Activity Relationship , Thiadiazines/chemical synthesis , Thiadiazines/metabolism , Triazoles/chemical synthesis , Triazoles/metabolism , Tubulin/chemistry , Tubulin Modulators/chemical synthesis , Tubulin Modulators/metabolism , Xenograft Model Antitumor Assays
4.
Cell Stress Chaperones ; 25(1): 119-131, 2020 01.
Article in English | MEDLINE | ID: mdl-31773487

ABSTRACT

Sogatella furcifera (Horváth), a prominent rice pest in Asia, is a typical R-strategic and highly adaptable insect. Heat shock proteins (Hsps) are highly conserved molecular chaperones regulating responses to various abiotic stresses; however, limited information is available regarding their role in responding to abiotic stress in S. furcifera. This study aimed to investigate the effect of abiotic stresses on the expression of Hsp70 genes in the S. furcifera. Five Hsp70 genes were isolated from S. furcifera, and the expression patterns at different developmental stages and temperatures, upon treatment with different insecticides and ultraviolet A (UV-A) stress, were analyzed. Hsp70 genes were expressed at different developmental stages. Hsp70-2, Hsp70-5, and Hsp70-6 were significantly upregulated upon heat shock at 40 °C for 30 min. Hsp70-3 and Hsp70-4 were significantly upregulated upon heat shock at 30 °C for 30 min. Under UV-A stress, Hsp70-3, Hsp70-4, Hsp70-5, and Hsp70-6 were significantly upregulated. Conversely, Hsp70-2 was significantly downregulated under UV-A stress. The five Hsp70 genes were significantly downregulated in 3rd-instar nymphs on exposure to thiamethoxam, buprofezin, and avermectin at LC10 and LC25 concentrations. Hence, Hsp70 genes significantly contribute to the tolerance of S. furcifera to temperature and UV-A stress; however, they are not involved in the response to insecticides.


Subject(s)
HSP70 Heat-Shock Proteins/genetics , Insecticides/pharmacology , Oryza/metabolism , Stress, Physiological , Animals , HSP70 Heat-Shock Proteins/metabolism , Insecticides/metabolism , Oryza/drug effects , Oryza/genetics , Stress, Physiological/drug effects , Stress, Physiological/physiology , Thiadiazines/metabolism , Thiadiazines/pharmacology , Transcriptome/drug effects , Transcriptome/genetics
5.
Biomed Chromatogr ; 33(6): e4492, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30673143

ABSTRACT

An analytical method for the determination of buprofezin residues in cabbage and cauliflower was developed and validated using gas chromatography with ion trap mass spectrometry. The analyte protectant d-sorbitol was used at a concentration level of 0.5 mg mL-1 in acetonitrile instead of in matrix for constructing the calibration curves of the buprofezin standard. The average recoveries ranged from 91.3 to 96.8%, with an RSD of ≤2.7%. The limits of detection and quantitation of the method in cabbage and cauliflower were 1.3, 1.7 and 4.3, 6.2 µg kg-1 , respectively. The residual levels and dissipation kinetics of buprofezin 25% wettabe powder in cabbage and cauliflower cultivated under open field conditions was investigated at the single (T1) and double (T2) recommended rates of application. Half-life periods were found to be 1.73 and 2.1 days in cabbage, whereas in cauliflower, these values were 1.85 and 2.36 days at T1 and T2, respectively. Based on the dissipation study, and the maximum residue limit value of 0.05 mg kg-1 , the proposed pre-harvest interval of buprofezin in cabbage was 3-6 days and that in cauliflower was 4-10 days. The results showed that buprofezin is safe for application at both recommended application rates.


Subject(s)
Brassica/chemistry , Gas Chromatography-Mass Spectrometry/methods , Pesticide Residues/analysis , Thiadiazines/analysis , Half-Life , Limit of Detection , Linear Models , Pesticide Residues/metabolism , Pesticide Residues/pharmacokinetics , Reproducibility of Results , Sorbitol/chemistry , Thiadiazines/metabolism , Thiadiazines/pharmacokinetics
6.
J Biomol Struct Dyn ; 37(9): 2339-2354, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30044206

ABSTRACT

Alzheimer disease (AD) is a cruel neurodegenerative disorder caused by the deposition of amyloid ß (Aß) peptide inside the brain. The ß-secretase (beta amyloid precursor protein (APP) cleaving enzyme 1, BACE1) is one of the enzymes involved in the cleavage of APP that leads to the Aß formation and it is the primary target for the treatment of AD. Recent report outlines that verubecestat molecule strongly inhibits BACE1; however, its structure, binding mechanism and the stability in the active site of BACE1 are not yet known. The present study aims to determine the structure, binding affinity and the stability of verubecestat molecule in the active site of BACE1 from the molecular docking, quantum mechanics/molecular mechanics (QM/MM)-based charge density analysis and molecular dynamics simulation. Verubecestat molecule was docked at BACE1; it shows high binding affinity towards BACE1. Further, the conformational geometry and the intermolecular interactions of verubecestat in the active site of BACE1 were determined. The molecule forms strong interaction with the neighboring amino acids in the active site of BACE1. The onsite QM/MM-based charge density analysis reveals the nature of charge density distribution and the topological properties of intermolecular interactions of verubecestat molecule in the active site of BACE1. The calculated electrostatic potential (ESP) of verubecestat in the active site of BACE1 displays high negative and positive ESP regions of the molecule. This onsite QM/MM analysis is more relevant to the physiological situation. The molecular dynamics simulation has been performed, which confirms the high stability and compactness of verubecestat in the active site of BACE1. The MM-generalized Born surface area and MM-Poisson Boltzmann surface area free energy calculations of verubecestat-BACE1 also confirm the high binding affinity of verubecestat. Communicated by Ramaswamy H. Sarma.


Subject(s)
Amyloid Precursor Protein Secretases/chemistry , Aspartic Acid Endopeptidases/chemistry , Cyclic S-Oxides/chemistry , Molecular Docking Simulation , Molecular Dynamics Simulation , Quantum Theory , Thiadiazines/chemistry , Alzheimer Disease/metabolism , Amyloid Precursor Protein Secretases/metabolism , Amyloid beta-Peptides/chemistry , Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/chemistry , Amyloid beta-Protein Precursor/metabolism , Aspartic Acid Endopeptidases/metabolism , Catalytic Domain , Cyclic S-Oxides/metabolism , Drug Stability , Humans , Protein Binding , Static Electricity , Thermodynamics , Thiadiazines/metabolism
7.
PLoS One ; 13(6): e0188245, 2018.
Article in English | MEDLINE | ID: mdl-29889848

ABSTRACT

BACKGROUND: Root-knot nematode (Meloidogyne spp., RKN) causes a disease that significantly reduces the yield of greenhouse cucumber crops year after year. Chemical control based on a single pesticide is now unreliable mainly due to pest resistance. Fumigant and non-fumigant pesticide combinations can potentially result in effective and economic RKN control. RESULTS: Combining the insecticide abamectin (ABM) with fumigants dazomet (DZ) or chloropicrin (CP) significantly extended the half-life of ABM by an average of about 1.68 and 1.56 times respectively in laboratory trials, and by an average of about 2.02 and 1.69 times respectively in greenhouse trials. Laboratory experiments indicated that all the low rate ABM combination treatments controlled RKN through a synergistic effect. ABM diffused into the nematode epidermis more rapidly when ABM was combined with DZ and CP, giving effective nematode control and an increase cucumber total yield, compared to the use of these products alone. ABM combined with CP or DZ produced significantly higher total cucumber yield than when these products were used alone. CONCLUSIONS: A low concentration of ABM combined with DZ in preference to CP would be an economic and practical way to control nematode and soilborne fungi in a greenhouse producing cucumbers.


Subject(s)
Cucumis sativus/parasitology , Hydrocarbons, Chlorinated/metabolism , Ivermectin/analogs & derivatives , Nematoda/metabolism , Soil/parasitology , Thiadiazines/metabolism , Animals , Ivermectin/metabolism
8.
Int J Mol Sci ; 18(12)2017 Nov 29.
Article in English | MEDLINE | ID: mdl-29186030

ABSTRACT

CYP353D1v2 is a cytochrome P450 related to imidacloprid resistance in Laodelphax striatellus. This work was conducted to examine the ability of CYP353D1v2 to metabolize other insecticides. Carbon monoxide difference spectra analysis indicates that CYP353D1v2 was successfully expressed in insect cell Sf9. The catalytic activity of CYP353D1v2 relating to degrading buprofezin, chlorpyrifos, and deltamethrin was tested by measuring substrate depletion and analyzing the formation of metabolites. The results showed the nicotinamide-adenine dinucleotide phosphate (NADPH)-dependent depletion of buprofezin (eluting at 8.7 min) and parallel formation of an unknown metabolite (eluting 9.5 min). However, CYP353D1v2 is unable to metabolize deltamethrin and chlorpyrifos. The recombinant CYP353D1v2 protein efficiently catalyzed the model substrate p-nitroanisole with a maximum velocity of 9.24 nmol/min/mg of protein and a Michaelis constant of Km = 6.21 µM. In addition, imidacloprid was metabolized in vitro by the recombinant CYP353D1v2 microsomes (catalytic constant Kcat) 0.064 pmol/min/pmol P450, Km = 6.41 µM. The mass spectrum of UPLC-MS analysis shows that the metabolite was a product of buprofezin, which was buprofezin sulfone. This result provided direct evidence that L. striatellus cytochrome P450 CYP353D1v2 is capable of metabolizing imidacloprid and buprofezin.


Subject(s)
Cytochrome P-450 Enzyme System/metabolism , Insecticides/pharmacology , Neonicotinoids/pharmacology , Nitro Compounds/pharmacology , Thiadiazines/metabolism , Animals , Hemiptera/drug effects , Hemiptera/metabolism
9.
J Environ Manage ; 180: 59-67, 2016 Sep 15.
Article in English | MEDLINE | ID: mdl-27208995

ABSTRACT

Given the intensive and widespread application of the pesticide, buprofezin, its environmental residues potentially pose a problem; yet little is known about buprofezin's kinetic and metabolic behaviors. In this study, a novel gram-positive strain, designated BF-5, isolated from aerobic activated sludge, was found to be capable of metabolizing buprofezin as its sole energy, carbon, and nitrogen source. Based on its physiological and biochemical characteristics, other aspects of its phenotype, and a phylogenetic analysis, strain BF-5 was identified as Bacillus sp. This study investigated the effect of culture conditions on bacterial growth and substrate degradation, such as pH, temperature, initial concentration, different nitrogen source, and additional nitrogen sources as co-substrates. The degradation rate parameters, qmax, Ks, Ki and Sm were determined to be 0.6918 h(-1), 105.4 mg L(-1), 210.5 mg L(-1), and 148.95 mg L(-1) respectively. The capture of unpublished potential metabolites by gas chromatography-mass spectrometry (GC-MS) analysis has led to the proposal of a novel degradation pathway. Taken together, our results clarify buprofezin's biodegradation pathway(s) and highlight the promising potential of strain BF-5 in bioremediation of buprofezin-contaminated environments.


Subject(s)
Bacillus/metabolism , Thiadiazines/metabolism , Bacillus/genetics , Bacillus/isolation & purification , Biodegradation, Environmental , Carbon/metabolism , Gas Chromatography-Mass Spectrometry , Hydrogen-Ion Concentration , Insecticides/metabolism , Kinetics , Metabolic Networks and Pathways , Nitrogen/metabolism , Phylogeny , Sewage/microbiology , Temperature
10.
Bioprocess Biosyst Eng ; 38(8): 1485-93, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25832788

ABSTRACT

Buprofezin is a commonly used chemical with satisfactory biological activity against sucking insect pests, but its disposal can cause serious environmental problems. To study the feasibility of remedying contamination by buprofezin, microcosm experiments were carried out to study the effects of various concentrations of buprofezin and Sphingobium sp. LY-6 on soil bacterial communities in soils collected from vegetable fields. In this experiment, the results showed that buprofezin was effectively degraded by Sphingobium sp. LY-6 in incubation soils. Comparing to non-incubated soils, the cumulative degradation ratio of buprofezin was significantly increased, up to the extent of 85 and 51%, in the initial concentration of 10 and 100 mg kg(-1). The abundance and community structure of the bacterial communities were analysed by real-time PCR (qPCR) and terminal-restriction fragment length polymorphism (T-RFLP). The findings suggest that buprofezin had a negative effect on soil bacterial community, and decreases in bacterial abundance were observed in the later part of the incubation period. The bacterial community structure and diversity shifted significantly at each sampling time. In conclusion, the buprofezin-degrading strain LY-6 played a major role in the bioremediation of the buprofezin-contaminated soil and influenced the dynamics and structure of the bacterial community, demonstrating the great potential of exogenous microorganisms for soil remediation.


Subject(s)
Microbial Consortia/physiology , Soil Microbiology , Soil , Thiadiazines/metabolism , Biodegradation, Environmental
11.
J Mol Graph Model ; 58: 40-9, 2015 May.
Article in English | MEDLINE | ID: mdl-25829097

ABSTRACT

Trypanosoma cruzi (T. cruzi) triosephosphate isomerase (TcTIM) is a glycolytic enzyme essential for parasite survival and has been considered an interesting target for the development of new antichagasic compounds. The homodimeric enzyme is catalytically active only as a dimer. Interestingly, significant differences exist between the human and parasite TIMs interfaces with a sequence identity of 52%. Therefore, compounds able to specifically disrupt TcTIM but not Homo sapiens TIM (hTIM) dimer interface could become selective antichagasic drugs. In the present work, the binding modes of 1,2,4-thiadiazol, phenazine and 1,2,6-thiadiazine derivatives to TcTIM were investigated using molecular docking combined with molecular dynamics (MD) simulations. The results show that phenazine and 1,2,6-thiadiazine derivatives, 2 and 3, act as dimer-disrupting inhibitors of TcTIM having also allosteric effects in the conformation of the active site. On the other hand, the 1,2,4-thiadiazol derivative 1 binds into the active site causing a significant decrease in enzyme mobility in both monomers. The loss of conformational flexibility upon compound 1 binding suggests that this inhibitor could be preventing essential motions of the enzyme required for optimal activity. The lack of inhibitory activity of 1 against hTIM was also investigated and seems to be related with the high mobility of hTIM which would hinder the formation of a stable ligand-enzyme complex. This work has contributed to understand the mechanism of action of this kind of inhibitors and could result of great help for future rational novel drug design.


Subject(s)
Enzyme Inhibitors/chemistry , Enzyme Inhibitors/metabolism , Triose-Phosphate Isomerase/antagonists & inhibitors , Trypanosoma cruzi/enzymology , Catalytic Domain , Drug Design , Enzyme Inhibitors/pharmacology , Molecular Docking Simulation , Molecular Dynamics Simulation , Phenazines/chemistry , Phenazines/metabolism , Thiadiazines/chemistry , Thiadiazines/metabolism , Thiadiazoles/chemistry , Thiadiazoles/metabolism , Triose-Phosphate Isomerase/chemistry , Triose-Phosphate Isomerase/metabolism
12.
Elife ; 3: e01603, 2014 Feb 11.
Article in English | MEDLINE | ID: mdl-24520162

ABSTRACT

The small molecule EMD 57033 has been shown to stimulate the actomyosin ATPase activity and contractility of myofilaments. Here, we show that EMD 57033 binds to an allosteric pocket in the myosin motor domain. EMD 57033-binding protects myosin against heat stress and thermal denaturation. In the presence of EMD 57033, ATP hydrolysis, coupling between actin and nucleotide binding sites, and actin affinity in the presence of ATP are increased more than 10-fold. Addition of EMD 57033 to heat-inactivated ß-cardiac myosin is followed by refolding and reactivation of ATPase and motile activities. In heat-stressed cardiomyocytes expression of the stress-marker atrial natriuretic peptide is suppressed by EMD 57033. Thus, EMD 57033 displays a much wider spectrum of activities than those previously associated with small, drug-like compounds. Allosteric effectors that mediate refolding and enhance enzymatic function have the potential to improve the treatment of heart failure, myopathies, and protein misfolding diseases. DOI: http://dx.doi.org/10.7554/eLife.01603.001.


Subject(s)
Cardiac Myosins/metabolism , Cardiotonic Agents/pharmacology , Enzyme Activators/pharmacology , Myocardial Contraction/drug effects , Myocytes, Cardiac/drug effects , Quinolines/pharmacology , Thiadiazines/pharmacology , Actins/metabolism , Adenosine Triphosphate/metabolism , Allosteric Regulation , Animals , Animals, Newborn , Binding Sites , Cardiac Myosins/chemistry , Cardiac Myosins/genetics , Catalytic Domain , Cells, Cultured , Dictyostelium , Dose-Response Relationship, Drug , Enzyme Activation , Enzyme Activators/metabolism , Humans , Hydrolysis , Kinetics , Molecular Docking Simulation , Myocytes, Cardiac/enzymology , Protein Conformation , Protein Refolding , Quinolines/metabolism , Rats , Recombinant Proteins/metabolism , Structure-Activity Relationship , Thiadiazines/metabolism
13.
World J Microbiol Biotechnol ; 30(2): 507-18, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23990067

ABSTRACT

Soil biofumigation with brassica plant residues has been shown to significantly suppress soilborne pathogen. However, little published data reported the impact of biofumigation on microbial community structure in pepper (Capsicum annuum L.) production systems under field conditions. Biofumigation with rapeseed (Brassica napus 'Dwarf Essex') meal and chemical fumigation with dazomet were tested to control the pepper disease caused by Phytophthora capsici. BF treatment showed the lowest disease incidence among these treatments. Effects on soil bacterial and fungal communities were assessed by denaturating gradient gel electrophoresis and the results showed that the biofumigation increased bacterial diversity and decreased fungal diversity. There was a negative correlation between soil bacterial diversity and disease incidence and a positive correlation between soil fungal diversity and disease incidence. Cloning of the microbial community showed that the microbial community structures were altered by biofumigation. Soil was also evaluated for their chemical properties. Biofumigation increased soil content of total N, NO3(-)-N, available P and available K. A significant correlation between soil microbial community structures and soil chemical properties was found. Overall, these results indicated that biofumigation reduced disease incidence of pepper through altering soil microbial community structures.


Subject(s)
Biota , Fumigation/methods , Phytophthora/growth & development , Plant Diseases/microbiology , Plant Diseases/prevention & control , Soil Microbiology , Anti-Infective Agents/metabolism , Brassica/metabolism , Capsicum/microbiology , Thiadiazines/metabolism
14.
Molecules ; 18(3): 3577-94, 2013 Mar 20.
Article in English | MEDLINE | ID: mdl-23519200

ABSTRACT

Three series of 3-(2-aminoheterocycle)-4-benzyloxyphenylbenzamide derivatives, 2-aminooxazoles, 2-aminothiazoles, and 2-amino-6H-1,3,4-thiadizines were designed, synthesized and evaluated as ß-secretase (BACE-1) inhibitors. Preliminary structure-activity relationships revealed that the existence of a 2-amino-6H-1,3,4-thiadizine moiety and α-naphthyl group were favorable for BACE-1 inhibition. Among the synthesized compounds, 5e exhibited the most potent BACE-1 inhibitory activity, with an IC50 value of 9.9 µΜ and it exhibited high brain uptake potential in Madin-Darby anine kidney cell lines (MDCK) and a Madin-Darby canine kidney-multidrug resistance 1 (MDCK-MDR1) model.


Subject(s)
Amyloid Precursor Protein Secretases/antagonists & inhibitors , Aspartic Acid Endopeptidases/antagonists & inhibitors , Naphthalenes/chemical synthesis , Protease Inhibitors/chemical synthesis , Thiadiazines/chemical synthesis , ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Amyloid Precursor Protein Secretases/chemistry , Animals , Aspartic Acid Endopeptidases/chemistry , Blood-Brain Barrier/metabolism , Cell Line , Dogs , Drug Design , Drug Evaluation, Preclinical , Humans , Naphthalenes/chemistry , Naphthalenes/metabolism , Permeability , Protease Inhibitors/chemistry , Protease Inhibitors/metabolism , Structure-Activity Relationship , Thiadiazines/chemistry , Thiadiazines/metabolism
15.
Eur J Pharmacol ; 691(1-3): 19-27, 2012 Sep 15.
Article in English | MEDLINE | ID: mdl-22760069

ABSTRACT

Glucocorticoid excess (Cushing's syndrome) causes metabolic syndrome such as visceral obesity, insulin resistance, diabetes mellitus, dyslipidaemia and hypertension. The selective inhibitors of 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD1) have considerable potential for treating type 2 diabetes mellitus and metabolic syndrome. In the present study, we investigated the anti-diabetic and anti-adipogenic effects of 4-(2-(1,1-dioxido-6-(2,4,6-trichlorophenyl)-1,2,6-thiadiazinan-2-yl)acetamido)adamantane-1-carboxamide (KR-67183), a novel selective 11ß-HSD1 inhibitor; we also investigated the underlying molecular mechanisms in the cortisone-induced 3T3-L1 adipogenesis model system and diet-induced obese (DIO) mice. KR-67183 concentration-dependently inhibited 11ß-HSD1 activity in human and mouse 11ß-HSD1 over-expressed cells and in the ex vivo assay of C57BL/6 mice. In the study with DIO mice, the administration of KR-67183 (20 and 50mg/kg/day, orally for 28 days) improved the glucose tolerance and insulin sensitivity with suppressed 11ß-HSD1 activity in the liver and fat. However, KR-67183 showed no change in the adrenal gland weight/body weight ratio and plasma corticosterone concentration in DIO mice. Further, KR-67183 suppressed adipocyte differentiation on cortisone-induced adipogenesis in 3T3-L1 cells is associated with the suppression of the cortisone-induced mRNA levels of FABP4, PPARγ2 and GLUT4, and 11ß-HSD1 activity. Taken together, it is suggested that a selective 11ß-HSD1 inhibitor, KR-67183, may provide a new therapeutic window in the prevention and treatment without toxicity in type 2 diabetes with obesity.


Subject(s)
11-beta-Hydroxysteroid Dehydrogenase Type 1/antagonists & inhibitors , Adamantane/analogs & derivatives , Adipogenesis/drug effects , Diet/adverse effects , Enzyme Inhibitors/pharmacology , Hypoglycemic Agents/pharmacology , Obesity/pathology , Thiadiazines/pharmacology , 11-beta-Hydroxysteroid Dehydrogenase Type 1/chemistry , 11-beta-Hydroxysteroid Dehydrogenase Type 1/metabolism , 3T3-L1 Cells , Adamantane/metabolism , Adamantane/pharmacology , Adipocytes/drug effects , Adipocytes/metabolism , Adipocytes/pathology , Adrenal Glands/drug effects , Adrenal Glands/physiopathology , Animals , Biomarkers/metabolism , CHO Cells , Cricetinae , Cricetulus , Enzyme Inhibitors/metabolism , Gene Expression Regulation/drug effects , Glucose Tolerance Test , Humans , Hypoglycemic Agents/metabolism , Hypothalamo-Hypophyseal System/drug effects , Hypothalamo-Hypophyseal System/physiopathology , Insulin Resistance , Mice , Molecular Docking Simulation , Obesity/etiology , Obesity/metabolism , Obesity/physiopathology , Protein Conformation , Thiadiazines/metabolism
16.
J Agric Food Chem ; 60(10): 2531-7, 2012 Mar 14.
Article in English | MEDLINE | ID: mdl-22335821

ABSTRACT

A buprofezin-degrading bacterium, YL-1, was isolated from rice field soil. YL-1 was identified as Rhodococcus sp. on the basis of the comparative analysis of 16S rDNA sequences. The strain could use buprofezin as the sole source of carbon and nitrogen for growth and was able to degrade 92.4% of 50 mg L(-1) buprofezin within 48 h in liquid culture. During the degradation of buprofezin, four possible metabolites, 2-tert-butylimino-3-isopropyl-1,3,5-thiadiazinan-4-one, N-tert-butyl-thioformimidic acid formylaminomethyl ester, 2-isothiocyanato-2-methyl-propane, and 2-isothiocyanato-propane, were identified using gas chromatography-mass spectrometry (GC-MS) analysis. The catechol 2,3-dioxygenase activity was strongly induced during the degradation of buprofezin. A novel microbial biodegradation pathway for buprofezin was proposed on the basis of these metabolites. The inoculation of soils treated with buprofezin with strain YL-1 resulted in a higher degradation rate than that observed in noninoculated soils, indicating that strain YL-1 has the potential to be used in the bioremediation of buprofezin-contaminated environments.


Subject(s)
Juvenile Hormones/metabolism , Oryza/microbiology , Rhodococcus/isolation & purification , Rhodococcus/metabolism , Soil Microbiology , Soil Pollutants/metabolism , Thiadiazines/metabolism , Biodegradation, Environmental , Oryza/growth & development , Rhodococcus/classification , Rhodococcus/genetics
17.
Biodegradation ; 22(6): 1135-42, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21380602

ABSTRACT

Buprofezin is a widely used insecticide that has caused environmental pollution in many areas. However, biodegradation of buprofezin by pure cultures has not been extensively studied, and the transformation pathway of buprofezin remains unclear. In this paper, a buprofezin co-metabolizing strain of DFS35-4 was isolated from a buprofezin-polluted soil in China. Strain DFS35-4 was preliminarily identified as Pseudomonas sp. based on its morphological, physiological, and biochemical properties, as well as 16S rRNA gene analysis. In the presence of 2.0 g l(-1) sodium citrate, strain DFS35-4 degraded over 70% of 50 mg l(-1) buprofezin in 3 days. Strain DFS35-4 efficiently degraded buprofezin in the pH range of 5.0-10.0 and at temperatures between 20 and 30°C. Three metabolites, 2-imino-5-phenyl-3-(propan-2-yl)-1,3,5-thiadiazinan-4-one, 2-imino-5-phenyl-1,3,5-thiadiazinan-4-one, and methyl(phenyl) carbamic acid, were identified during the degradation of buprofezin using gas chromatography-mass spectrometry (GC-MS) and tandem mass spectrometry (MS/MS). A partial transformation pathway of buprofezin in Pseudomonas sp. DFS35-4 was proposed based on these metabolites.


Subject(s)
Biodegradation, Environmental , Insecticides/metabolism , Pseudomonas/enzymology , Soil Microbiology , Soil Pollutants/metabolism , Thiadiazines/metabolism , Biotransformation , China , Culture Media , Gas Chromatography-Mass Spectrometry , Phylogeny , Pseudomonas/isolation & purification , RNA, Ribosomal, 16S/genetics , RNA, Ribosomal, 16S/metabolism , Soil/chemistry
18.
Free Radic Biol Med ; 47(7): 953-61, 2009 Oct 01.
Article in English | MEDLINE | ID: mdl-19576981

ABSTRACT

15(S)-Hydroperoxy-[5Z,8Z,11Z,13E]-eicosatetraenoic acid (15(S)-HpETE) undergoes homolytic decomposition to bifunctional electrophiles such as 4-oxo-2(E)-nonenal. 4-Oxo-2(E)-nonenal reacts with glutathione to form a thiadiazabicyclo-4-oxo-2(E)-nonenal-glutathione adduct (TOG). Therefore, this endogenous glutathione adduct can serve as a specific biomarker of lipid hydroperoxide-mediated 4-oxo-2(E)-nonenal formation. A monocyte/macrophage cell line was generated to constitutively express human 15-lipoxygenase-1. In these cells, TOG was formed from 15(S)-HpETE-derived 4-oxo-2(E)-nonenal in a nonlinear dose-dependent manner upon arachidonic acid treatment. The lipoxygenase inhibitor cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate abolished arachidonic acid-mediated TOG formation. The calcium ionophore A23187 was also used to induce the formation of 15(S)-HpETE from esterified arachidonic acid present in the membrane lipids. In the 15-lipoxygenase-1-expressing cells, the calcium ionophore A23187 significantly increased TOG levels compared with mock-transfected cells. This was due to the 15-lipoxygenase-mediated formation of 15(S)-HpETE in the forms of free fatty acid and esterified lipids, which was subsequently converted to 4-oxo-2(E)-nonenal. The increase in TOG formation was again abrogated by pretreatment with cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate. Only 8.7% 15(S)-HETE (both the free fatty acid and its esterified form in the cell membrane) was formed after ionophore A23187 stimulation compared with that formed after the addition of arachidonic acid. In contrast, the TOG levels after treatment with ionophore A23187 or arachidonic acid were comparable. Thus, it is likely that esterified 15(S)-HpETE underwent homolytic decomposition to 4-oxo-2(E)-nonenal more efficiently than the free 15(S)-HpETE that was formed in the cytosol.


Subject(s)
Aldehydes/metabolism , Arachidonate 15-Lipoxygenase/metabolism , Arachidonic Acid/metabolism , Cytosol/metabolism , Glutathione/metabolism , Thiadiazines/metabolism , Aldehydes/chemical synthesis , Aldehydes/chemistry , Animals , Arachidonate 15-Lipoxygenase/chemistry , Arachidonic Acid/chemistry , Cells, Cultured , Cytosol/chemistry , Esterification , Glutathione/chemical synthesis , Glutathione/chemistry , Humans , Mice , Molecular Conformation , Oxidation-Reduction , Stereoisomerism , Thiadiazines/chemical synthesis , Thiadiazines/chemistry
19.
Molecules ; 12(3): 297-303, 2007 Mar 03.
Article in English | MEDLINE | ID: mdl-17851388

ABSTRACT

A series of 6-aryl-3-(3-hydroxypropyl)-7H-1,2,4-triazolo[3,4-b][1,3,4]-thiadiazines were synthesized by the reaction of 4-amino-3-(3-hydroxypropyl)-5-mercapto-1,2,4-triazole (1) with substituted omega-haloacetophenones. Their structures were confirmed by elemental analysis, IR, 1H-NMR, and 13C-NMR. Tests of plant growth regulating effects showed that the title compounds display remarkable inhibitory activities on the growth of radish and wheat.


Subject(s)
Thiadiazines/chemical synthesis , Thiadiazines/metabolism , Triazoles/chemical synthesis , Triazoles/metabolism , Carbon Isotopes , Germination/drug effects , Magnetic Resonance Spectroscopy , Plant Growth Regulators/pharmacology , Plant Roots/drug effects , Plant Shoots/drug effects , Raphanus/drug effects , Spectrophotometry, Infrared , Thiadiazines/chemistry , Thiadiazines/pharmacology , Triazoles/chemistry , Triazoles/pharmacology , Triticum/drug effects
20.
J Aerosol Med ; 20(3): 282-93, 2007.
Article in English | MEDLINE | ID: mdl-17894535

ABSTRACT

Antibiotic drugs exhibit concentration dependence in their efficacy. Therefore, ensuring appropriate concentration of these drugs in the relevant body fluid is important for obtaining the desired therapeutic and physiological action. Until recently there had been no suitable method available to measure or estimate concentration of drugs in the human airways resulting from inhaled aerosols or to determine the amount of inhaled antibiotics required to ensure minimum inhibitory concentration of a drug in the airway surface liquid (ASL). In this paper a numerical method is used for estimating local concentration of inhaled pharmaceutical aerosols in different generations of the human tracheobronchial airways. The method utilizes a mathematical lung deposition model to estimate amounts of aerosols depositing in different lung generations, and a recent ASL model along with deposition results to assess the concentration of deposited drugs immediately following inhalation. Examples of concentration estimates for two case studies: one for the antibiotic tobramycin against Pseudomonas aeruginosa, and another for taurolidine against Burkholderia cepacia are presented. The aerosol characteristics, breathing pattern and properties of nebulized solutions were adopted from two recent clinical studies on efficacy of these drugs in cystic fibrosis (CF) patients and from other sources in the literature. While the clinically effective tobramycin showed a concentration higher than the required in vivo concentration, that for the ineffective taurolidine was found to be below the speculated required in vivo concentration. Results of this study thus show that the mathematical ASL model combined with the lung deposition model can be an effective tool for helping decide the optimum dosage of inhaled antibiotic drugs delivered during human clinical trials.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Burkholderia Infections/drug therapy , Cystic Fibrosis/drug therapy , Nebulizers and Vaporizers , Pseudomonas Infections/drug therapy , Respiratory System/metabolism , Taurine/analogs & derivatives , Thiadiazines/administration & dosage , Tobramycin/administration & dosage , Administration, Inhalation , Aerosols , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/metabolism , Burkholderia Infections/metabolism , Burkholderia Infections/microbiology , Burkholderia Infections/physiopathology , Burkholderia cepacia/drug effects , Burkholderia cepacia/growth & development , Burkholderia cepacia/isolation & purification , Computer Simulation , Cystic Fibrosis/metabolism , Cystic Fibrosis/microbiology , Cystic Fibrosis/physiopathology , Dose-Response Relationship, Drug , Humans , Microbial Sensitivity Tests , Models, Biological , Particle Size , Pseudomonas Infections/metabolism , Pseudomonas Infections/microbiology , Pseudomonas Infections/physiopathology , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/growth & development , Pseudomonas aeruginosa/isolation & purification , Research Design , Respiratory Mechanics , Respiratory System/microbiology , Respiratory System/physiopathology , Sputum/metabolism , Sputum/microbiology , Taurine/administration & dosage , Taurine/chemistry , Taurine/metabolism , Thiadiazines/chemistry , Thiadiazines/metabolism , Tobramycin/chemistry , Tobramycin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL